These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9625403)

  • 1. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease.
    McBride P; Schrott HG; Plane MB; Underbakke G; Brown RL
    Arch Intern Med; 1998 Jun; 158(11):1238-44. PubMed ID: 9625403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of high blood cholesterol by primary care physicians: diffusion of the National Cholesterol Education Program Adult Treatment Panel guidelines.
    Shea S; Gemson DH; Mossel P
    J Gen Intern Med; 1990; 5(4):327-34. PubMed ID: 2374043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial.
    Eaton CB; Parker DR; Borkan J; McMurray J; Roberts MB; Lu B; Goldman R; Ahern DK
    Ann Fam Med; 2011; 9(6):528-37. PubMed ID: 22084264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care.
    Virani SS; Wang D; Woodard LD; Chitwood SS; Landrum CR; Zieve FJ; Ballantyne CM; Petersen LA
    J Clin Lipidol; 2012; 6(6):545-52. PubMed ID: 23312050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial.
    Bertoni AG; Bonds DE; Chen H; Hogan P; Crago L; Rosenberger E; Barham AH; Clinch CR; Goff DC
    Arch Intern Med; 2009 Apr; 169(7):678-86. PubMed ID: 19364997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.
    Frolkis JP; Zyzanski SJ; Schwartz JM; Suhan PS
    Circulation; 1998 Sep; 98(9):851-5. PubMed ID: 9738639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.
    O'Connor PJ; Gray RJ; Maciosek MV; Fillbrandt KM; DeFor TA; Alexander CM; Weiss TW; Teutsch SM
    Prev Chronic Dis; 2005 Jul; 2(3):A05. PubMed ID: 15963307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study.
    Paragh G; Márk L; Zámolyi K; Pados G; Ofner P
    Clin Drug Investig; 2007; 27(9):647-60. PubMed ID: 17705573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.
    Persell SD; Zei C; Cameron KA; Zielinski M; Lloyd-Jones DM
    Arch Intern Med; 2010 Mar; 170(5):470-7. PubMed ID: 20212185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
    Saposnik G; Goodman SG; Leiter LA; Yan RT; Fitchett DH; Bayer NH; Casanova A; Langer A; Yan AT; ; ;
    Stroke; 2009 Apr; 40(4):1417-24. PubMed ID: 19213947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaps in cardiovascular disease risk management in Australian general practice.
    Webster RJ; Heeley EL; Peiris DP; Bayram C; Cass A; Patel AA
    Med J Aust; 2009 Sep; 191(6):324-9. PubMed ID: 19769555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic gap--compliance with medication and guidelines.
    Feely J
    Atherosclerosis; 1999 Sep; 147 Suppl 1():S31-7. PubMed ID: 10575060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degree of Lipid Control in Patients With Coronary Heart Disease and Measures Adopted by Physicians. REPAR Study.
    Galve E; Cordero A; Cequier A; Ruiz E; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):931-938. PubMed ID: 27178117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.